1224 related articles for article (PubMed ID: 19010164)
21. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
[TBL] [Abstract][Full Text] [Related]
22. Liver transplantation using donors older than 80 years: a single-center experience.
Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
[TBL] [Abstract][Full Text] [Related]
23. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
[TBL] [Abstract][Full Text] [Related]
25. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
[TBL] [Abstract][Full Text] [Related]
27. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
[TBL] [Abstract][Full Text] [Related]
28. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China.
Xiao L; Fu ZR; Ding GS; Fu H; Ni ZJ; Wang ZX; Shi XM; Guo WY
Transplant Proc; 2009 Jun; 41(5):1717-21. PubMed ID: 19545714
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale PL; Beltrami CA; Bresadola F
Transplant Proc; 2006 May; 38(4):1111-3. PubMed ID: 16757280
[TBL] [Abstract][Full Text] [Related]
31. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
32. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
33. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis.
Park YK; Kim BW; Wang HJ; Kim MW
Transplant Proc; 2009 Jun; 41(5):1691-7. PubMed ID: 19545709
[TBL] [Abstract][Full Text] [Related]
34. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
35. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
[TBL] [Abstract][Full Text] [Related]
36. Indications and management of everolimus after liver transplantation.
Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R
Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864
[TBL] [Abstract][Full Text] [Related]
37. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
[TBL] [Abstract][Full Text] [Related]
38. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
[TBL] [Abstract][Full Text] [Related]
39. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
Llovet JM; Bruix J; Fuster J; Castells A; Garcia-Valdecasas JC; Grande L; Franca A; Brú C; Navasa M; Ayuso MC; Solé M; Real MI; Vilana R; Rimola A; Visa J; Rodés J
Hepatology; 1998 Jun; 27(6):1572-7. PubMed ID: 9620329
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
Sotiropoulos GC; Malagó M; Bockhorn M; Schmitz KJ; Radtke A; Molmenti EP; Schaffer R; Beckebaum S; Cicinnati VR; Fouzas I; Broelsch CE; Lang H
Hepatogastroenterology; 2008; 55(86-87):1671-7. PubMed ID: 19102367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
